Clarity Pharmaceuticals Ltd.ASX: CU6

Recruitment target achieved for Phase II SAR-Bombesin trial

Nov 7, 2023 at 3:51 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment